TUMOR DEVELOPMENT RESEARCH

cell-bullet4.jpg La Jolla Institute for Allergy & Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia. Myeloproliferative diseases are a group of disorders characterized by an overproduction of blood cells by the bone marrow and include chronic myeloid leukemia.  Lymphoma and leukemia are cancers of the blood.

"PLC-beta 3 is an enzyme, but the function we found was a completely different function that no one knew it had  -- as a tumor suppressor," said the La Jolla Institute's Toshiaki  Kawakami, M.D., Ph.D., who led the research team.  The study, conducted in animal models, could eventually lead to the development of new therapies directed towards controlling this newly discovered cellular mechanism.  Read the Full Story

faculty appointments
how to help
news
  • 7/20/2010 - News Release
    La Jolla Institute Teams with Dana-Farber and Washington University on Sickle Cell Clinical Trial
    News Release link
  • 6/29/2010 - News Release
    La Jolla Institute Elects Broadcom's John Major as Board Chairman
    News Release link
  • 6/24/2010 - UCSD-TV
    Taking Control of Your Diabetes: Diabetes Prevention
    Matthias von Herrath, M.D.
    Video page
  • More News
upcoming seminars
  • *** Summer Break *** 
  • Bridget Wilson,  "TBD",  Wednesday, 09/01/10: 12:00 PM
  • More Seminars
fact-amer-cancer-soc.gif